| Primary |
| Hypertension |
65.6% |
| Insomnia |
3.8% |
| Asthma |
2.9% |
| Essential Hypertension |
2.9% |
| Hyperphosphataemia |
2.9% |
| Hyperuricaemia |
2.4% |
| Anaemia |
1.9% |
| Azotaemia |
1.9% |
| Constipation |
1.9% |
| Gastritis |
1.9% |
| Therapeutic Response Decreased |
1.9% |
| Benign Prostatic Hyperplasia |
1.4% |
| Ill-defined Disorder |
1.4% |
| Preoperative Care |
1.4% |
| Atrial Fibrillation |
1.0% |
| Cough |
1.0% |
| Diabetes Mellitus |
1.0% |
| Gastric Ulcer |
1.0% |
| Hyperlipidaemia |
1.0% |
| Raynaud's Phenomenon |
1.0% |
|
| Interstitial Lung Disease |
8.3% |
| Rhabdomyolysis |
8.3% |
| Hypoglycaemia |
6.9% |
| Pancytopenia |
6.9% |
| Suicide Attempt |
6.9% |
| Blood Pressure Increased |
5.6% |
| Phaeochromocytoma |
5.6% |
| Renal Impairment |
5.6% |
| Dizziness |
4.2% |
| Ejaculation Disorder |
4.2% |
| Ejaculation Failure |
4.2% |
| Erectile Dysfunction |
4.2% |
| Platelet Count Decreased |
4.2% |
| Rheumatoid Factor Increased |
4.2% |
| Vasculitis |
4.2% |
| Visual Acuity Reduced |
4.2% |
| Visual Impairment |
4.2% |
| Blood Creatinine Increased |
2.8% |
| Cardiac Failure |
2.8% |
| Diabetes Insipidus |
2.8% |
|
| Secondary |
| Hypertension |
55.0% |
| Drug Use For Unknown Indication |
6.0% |
| Insomnia |
5.6% |
| Gastritis |
3.4% |
| Hyperuricaemia |
3.2% |
| Oedema |
2.6% |
| Renal Failure Chronic |
2.2% |
| Retinal Haemorrhage |
2.2% |
| Nephrogenic Anaemia |
2.1% |
| Bronchitis |
1.9% |
| Hyperlipidaemia |
1.9% |
| Upper Respiratory Tract Infection |
1.9% |
| Product Used For Unknown Indication |
1.7% |
| Type 2 Diabetes Mellitus |
1.7% |
| Benign Prostatic Hyperplasia |
1.5% |
| Constipation |
1.5% |
| Hyperkalaemia |
1.5% |
| Hypoglycaemia |
1.5% |
| Infection |
1.5% |
| Atrial Fibrillation |
1.3% |
|
| Liver Disorder |
10.0% |
| Hypoglycaemia |
8.8% |
| Cardiac Failure |
7.5% |
| Interstitial Lung Disease |
7.5% |
| Renal Failure Acute |
7.5% |
| Eosinophil Count Increased |
5.0% |
| Thrombocytopenia |
5.0% |
| Hypoglycaemic Unconsciousness |
3.8% |
| Hypokalaemia |
3.8% |
| Hypotension |
3.8% |
| Pancytopenia |
3.8% |
| Phlebitis |
3.8% |
| Platelet Count Decreased |
3.8% |
| Proteinuria |
3.8% |
| Renal Failure |
3.8% |
| Shock |
3.8% |
| Upper Respiratory Tract Inflammation |
3.8% |
| Vasculitis |
3.8% |
| White Blood Cell Count Increased |
3.8% |
| Wound |
3.8% |
|
| Concomitant |
| Hypertension |
49.4% |
| Drug Use For Unknown Indication |
5.2% |
| Diabetes Mellitus |
4.9% |
| Product Used For Unknown Indication |
4.3% |
| Rheumatoid Arthritis |
3.8% |
| Prophylaxis |
3.2% |
| Gastritis |
3.1% |
| Constipation |
2.8% |
| Insomnia |
2.5% |
| Nephrogenic Anaemia |
2.5% |
| Chronic Hepatitis C |
2.2% |
| Hyperlipidaemia |
2.2% |
| Angina Pectoris |
2.1% |
| Hyperuricaemia |
2.0% |
| Pain |
1.9% |
| Psoriasis |
1.8% |
| Herpes Zoster |
1.8% |
| Gastric Ulcer |
1.5% |
| Type 2 Diabetes Mellitus |
1.4% |
| Hyperphosphataemia |
1.3% |
|
| Renal Impairment |
12.7% |
| Vomiting |
9.4% |
| Interstitial Lung Disease |
6.8% |
| Pyrexia |
5.9% |
| Renal Failure Acute |
5.2% |
| Rhabdomyolysis |
5.2% |
| Renal Failure Chronic |
4.9% |
| Cardiac Failure |
4.6% |
| Hepatic Function Abnormal |
4.6% |
| Hyperkalaemia |
4.2% |
| Somnolence |
4.2% |
| Urinary Tract Infection |
4.2% |
| Nervous System Disorder |
3.9% |
| Platelet Count Decreased |
3.9% |
| Renal Disorder |
3.9% |
| Anaemia |
3.3% |
| Liver Disorder |
3.3% |
| Pneumonia |
3.3% |
| Ventricular Tachycardia |
3.3% |
| White Blood Cell Count Increased |
3.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
50.0% |
| Hypertension |
25.0% |
| Nail Tinea |
25.0% |
|
|
